“The Reply to the Letter to the Editor Regarding: ‘The Autologous CaTeVac Dendritic Cell Vaccine in Patients With Melanoma: Final Results of the DENDRON-01 Study’”. 2026. Voprosy Onkologii 72 (1): OF-2568. https://doi.org/10.37469/0507-3758-2026-72-1-OF-2568.